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Abstract 
The maintenance of homeostasis in normal tissues reflects a balance between cell proliferation and cell death. Bcl-2 inaugurated a new 
category of oncogenes, regulators of cell death. The Bcl-2 gene was identified at the chromosomal breakpoint of t(14; 18) bearing B cell 
lymphomas. Bcl-2 proved unique by blocking programmed cell death rather than promoting proliferation. In adults, Bcl-2 is 
topographically restricted to progenitor cells and longlived cells but is much more widespread in the developing embryo. Transgenic mice 
that overexpress Bcl-2 demonstrate extended cell survival, and progress to high grade lymphomas. Bcl-2 has been localized to 
mitochondria, endoplasmic reticulum and nuclear membranes, also the sites of reactive oxygen species generation. Bcl-2 does not appear 
to influence the generation of oxygen free radicals but does prevent oxidative damage to cellular constituents including lipid membranes. 
Bcl-2 deficient mice complete mbryonic development but undergo fulminant lymphoid apoptosis of thymus and spleen. Moreover, they 
demonstrate wo unexpected pathologies resulting from cell death, polycystic kidney disease and hair hypopigmentation. The latter is a 
potential oxidant injury from the melanin biosynthetic pathway. A family of Bcl-2 related genes is emerging that includes Bax, a 
conserved homolog that heterodimerizes in vivo with Bcl-2 and promotes cell death. The ratio of family members, such as Bcl-2/Bax, 
determines the survival or death of cells following an apoptotic stimulus. 
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1. Bcl-2 initiates a new category of oncogenes: regula- 
tors of cell death 
Malignancies usually possess aberrations in more than a 
single pathway [1]. Either increased proliferation or de- 
creased eath might result in an expansion of cell numbers 
(Fig. l). To date, most of our knowledge concerning 
oncogenic events has concentrated upon mechanisms of 
increased growth and proliferation. Studies of Bcl-2 em- 
phasize the existence of multiple pathways in the genera- 
tion of neoplasia (Fig. 1). The increased cell number in 
neoplastic tissue can be viewed as a violation of normal 
homeostasis. The maintenance of homeostasis in normal 
tissue, in many respects, reflects a simple balanced equa- 
tion of input (cellular proliferation and renewal) versus 
output (cell death). The maintenance of remarkably invari- 
ant cell numbers must reflect tightly regulated eath path- 
ways as well as controlled proliferation (Fig. 1). 
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Programmed cell death represents a cell autonomous 
suicide pathway that helps restrict cell numbers. The well- 
defined loss of specific cells is crucial during embryonic 
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Fig. 1. Schematic representation of normal tissue homeostasis with 
balanced input and output reactions. Alternative roads to neoplasia re 
depicted as either increased proliferation (In) or decreased eath (Out). 
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development [1]. In mature tissues, genetically pro- 
grammed emise regulates the numbers of cells. A mor- 
phologically distinct and highly characteristic process enti- 
tled apoptosis accounts for these cell deaths [2]. Cells 
dying by apoptosis display marked plasma membrane bleb- 
bing, volume contraction, nuclear condensation, and the 
activation of an endonuclease that cleaves DNA into nucle- 
osomal length fragments. Defining the precise genes and 
biochemical events that regulate this death program holds 
the promise for novel therapeutic approaches. 
thymocytes protected them from a wide variety of apop- 
totic stimuli including glucocorticoids, radiation, and anti- 
CD3 treatment. Moreover, Bcl-2 promoted T cell matura- 
tion. Bcl-2 enabled further T cell development obviating 
the need for several critical signals normally required for 
maturation [17]. This suggests that if cell death can be 
repressed inherent differentiation programs will manifest. 
3. Bcl-2's localization: a clue to its function? 
2. Bcl-2 represses programmed cell death 
The t(14;18) (q32;q21) constitutes the most common 
chromosomal translocation i human lymphoid malignan- 
cies. Approximately 85% of follicular and 20% of diffuse 
B cell lymphomas possess this translocation [3,4]. Aberrant 
Ig heavy chain gene rearrangements on 14q32 proved to be 
the chromosomal breakpoint and delivered a candidate 
oncogene, Bcl-2, at 18q21 [5-7]. 
Whether the newly discovered genes found at chromo- 
somal breakpoints could be shown to be transforming 
remained a major question. Bcl-2 conferred a death sparing 
effect to certain hematopoietic cell lines following growth 
factor withdrawal [8-10]. A stringent est of a gene's 
oncogenic apacity is to place it into the germline of mice 
to observe its effects during the development of an entire 
organism. Transgenic mice bearing a Bcl-2-Ig minigene 
initially displayed a polyclonal follicular lymphoprolifera- 
tion that selectively expanded a small resting IgM/IgD B 
cell population. Cell cycle analysis confirmed that ~ 97% 
of the expanded B cells reside in Go/GI .  These recirculat- 
ing B cells accumulate because of an extended survival 
rather than increased proliferation [11,12]. Over time these 
transgenics progress from indolent follicular hyperplasia to 
diffuse large cell immunoblastic lymphoma [13]. A long 
latency period and progression from polyclonal hyperpla- 
sia to monoclonal high-grade malignancy is an indictment 
of secondary genetic abnormalities. Approximately half of 
the high grade tumors possess a c-myc translocation i - 
volving an IgH chain locus. These tumor cells have com- 
plemented an inherent survival advantage (Bcl-2) with a 
gene that promotes proliferation (myc). In addition to 
promoting cell cycle progression myc has been shown to 
promote apoptosis [14]. Thus, the overexpression f myc 
may specifically benefit from Bcl-2's ability to block 
apoptosis. Finally, the Bcl-2-Ig mice document the 
prospective importance of the t(14;18) in setting the stage 
for tumor progression and lymphomagenesis. 
To assess the role of Bcl-2 in T cell development 
transgenic mice were generated in which Bcl-2 was redi- 
rected to the immature T cells in the cortex of the thymus 
[15]. A separate transgenic model also overexpressed Bcl-2 
in the thymus and displayed similar effects [16]. The 
introduction of Bcl-2 into the normally vulnerable cortical 
Bcl-2 has a COOH-terminal hydrophobic region that 
functions as a signal-anchor sequence responsible for the 
integral membrane position of the 25 kDa Bcl-2 ce product 
[18,19]. Bcl-2 has been localized most convincingly to 
mitochondria, endoplasmic reticulum and nuclear mem- 
brane [9,20,21]. Mitochondrial fractionation methods 
placed Bcl-2 predominantly in the inner membrane; 
whereas, immunoelectron microscopy and in vitro target- 
ing showed more in the outer mitochondrial membrane. In
vitro targeting studies indicate that while Bcl-2 can target 
microsomes, it selectively integrates into the outer mem- 
brane of mitochondria with its NH2-terminus facing the 
cytosol [19]. COOH-terminus of Bcl-2 possesses a 19 
amino acid hydrophobic tail bordered by positively charged 
amino acids that function as a signal/anchor sequence 
responsible for its integral membrane position. Of note the 
core of the Bcl-2 signal/anchor shares some homology 
with the corresponding region of the NH2-terminal 
signal/anchor of the mitochondrial outer membrane pro- 
tein in yeast, Mas70p. A Mas70p signal anchor peptide 
competed for insertion of Bcl-2 into the outer mitochon- 
drial membrane but had no effect upon Bcl-2's association 
with endoplasmic reticulum. Indeed replacement of Bcl-2's 
signal/anchor with that of Mas70p resulted in a functional 
hybrid molecule that displayed a similar distribution to 
Bcl-2, still heterodimerized with Bax, and repressed cell 
death [22]. An anchor-minus form of Bcl-2, Bcl-2 AC22, 
retained about half of its activity, but could still het- 
erodimerize with membrane bound Bax [23]. Overall, the 
data favor a model in which Bcl-2 family members are 
targeted to strategic membrane locations within the cell, 
with the NH2-terminus of the proteins available for cytoso- 
lic interactions. 
4. Evidence for reactive oxygen species in cell death 
Bcl-2's ability to block yirradiation-induced cell death 
is notable in that ionizing radiation amongst its effects 
produces hydroxyl radicals (OH') by radiolytic attack on 
H20. The intracellular sites of oxygen free radical genera- 
tion include mitochondria, endoplasmic reticulum and per- 
haps nuclear membranes; the sites where Bcl-2 has also 
been localized. Many of the effects of oxygen free radicals 
including DNA strand breaks and membrane blebbing 
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Fig. 2. Schematic representation of some major pathways ofoxygen free 
radical generation a d detoxification within cells that may be operative in
cell death. 
match the hallmark features of apoptosis, prompting an 
examination of Bcl-2's ability to counter other oxidative 
cell deaths. Bcl-2 protected cells from the lethal effects of 
H202 or t-butyl hydroperoxide in a dose-dependent man- 
ner [23,24]. At low concentrations these deaths resemble 
apoptosis. Bcl-2 also interfered with cell death induced by 
menadione, a quinone compound which undergoes redox 
cycles intracellularly to generate superoxide, O~. Impor- 
tantly Bcl-2 could not prevent the oxidative burst gener- 
ated by menadione. Moreover, oximetry studies in two 
separate model systems of apoptosis revealed no evidence 
for any burst in the production of reactive oxygen species. 
Moreover, overexpression of Bcl-2 did not alter the effi- 
ciency of normal electron transport nor the production of 
peroxides. Consistent with this, rho ° cells have been shown 
to undergo apoptosis which is also blocked by bcl-2 [21]. 
However, Bcl-2 completely suppressed amage to vital 
structures including the peroxidation of lipid membranes 
[23]. Consistent with this finding, overexpression of glu- 
tathione peroxidase (GSHPx), a known inhibitor of lipid 
peroxidation, repressed apoptosis. Which reactive oxygen 
species (ROS) might be important in cell death (Fig. 2)? 
Mutations within Cu /ZnSOD in familial cases of amy- 
otrophic lateral sclerosis argue for an oxygen-radical medi- 
ated loss of motor neurons in that disease [25]. Data from 
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Fig. 3. Bcl-2 gene family. An expanding family of proteins homologous 
to Bcl-2 are most highly conserved within Bcl-2 homology 1and 2 (BHI 
and BH2) domains. Identical amino acids in black background and 
conserved positions in gray background. 
apoptosis systems implicate peroxides as an important 
ROS perhaps reflecting the diffusibility of H202 or its 
proclivity for conversion to the most highly reactive OH 
radical (Fig. 2). Bcl-2 appears to block damage between 
peroxide generation and lipid membrane peroxidation. 
Whether this effect is direct or is several steps removed 
remains an important question. Bcl-2 has also been shown 
to inhibit necrotic forms of cell death. As H202 or mena- 
dione doses are increased the deaths resemble necrosis, 
and Bcl-2 displays an ability to retard these deaths within 
the lower range of oxidative stress. This also includes 
depletion of glutathione from neuronal cell lines [24]. If 
ROS prove to mediate demise in both apoptosis and 
necrosis it may be they represent a continuum of cell 
destruction rather than distinct pathways. 
5. Bcl-2/bax: a cell autonomous rheostat controls cell 
death 
Bcl-2 is a member of a multicomponent complex that 
includes a 21 kDa partner, Bax (Bcl-2 associated X pro- 
tein) [26]. Of note Bax shares homology with Bcl-2 princi- 
pally clustered within 2 highly conserved regions, Bcl-2 
homology 1 and 2 (BHI and BH2) domains (Fig. 3). It 
was possible that Bax worked in concert with Bcl-2 to 
repress death or that this association represented 'hand to 
hand' combat in which Bax promoted death while Bcl-2 
opposed it. The latter proved to be the case in that excess 
Bax countered Bcl-2 and accelerated apoptotic ell death, 
but only following a death signal. Of note, the Bcl-2/Bax 
association exists in cells prior to a death stimulus. When 
Bcl-2 is in excess Bcl-2 homodimers dominate and cells 
are protected. When Bax is in excess Bax homodimers 
dominate and cells are susceptible to apoptosis (Fig. 4) 
[26]. A number of biologic systems indicate that cells vary 
during development in their inherent sensitivity or resis- 
CELL AUTONOMOUS RHEOSTAT OF 
PROGRAMMED CELL DEATH 
Fig. 4. Cell autonomous rheostat regulates cell death. Bcl-2 and Bax form 
homodimers and heterodimers. Following a signal for programmed cell 
death (PCD) cells die if Bax is in excess, but live if Bcl-2 predominates. 
Mutagenesis tudies uggest that Bcl-2 homodimers may not be the active 
moiety. 
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tance to a given death stimulus. The ratio of Bcl-2/Bax 
represents one cell autonomous rheostat that pre-de- 
termines a cell's life or death response to an apoptotic 
stimulus. 
6. Bhl and bh2 are novel motifs which regulate dimer- 
ization 
An emerging family of Bcl-2 related proteins are princi- 
pally defined by the presence of conserved BHI and BH2 
domains (Fig. 3). The fact that Bax heterodimerizes with 
Bcl-2 and counters Bcl-2 suggested that these domains 
would participate in function or protein interaction. Site 
specific mutagenesis of Bcl-2 established BH1 and BH2 as 
novel dimerization motifs [27]. Single amino acid substitu- 
tions within BH1 or BH2 were identified that completely 
abrogated Bcl-2's death repressor activity. Of interest, 
those mutations that affected Bcl-2's function also dis- 
rupted its heterodimerization with Bax, yet still permitted 
Bcl-2 homodimerization. These data favor a model in 
which Bcl-2 must bind Bax to exert its activity, and 
suggest that Bcl-2/Bax heterodimers or Bax/Bax homod- 
imers may prove to be the active pair in regulating death 
(Fig. 4). 
tion and oxidative polymerization to form the insoluble 
heteropolymers of eumelanin. In this process the produc- 
tion of light or dark melanin is regulated by cellular edox 
potential. Thus, in the absence of Bcl-2 melanin pathway 
derived free radicals could impact melanocyte survival in 
Bcl-2 - / -  animals. 
Overtime Bcl-2 - / -  mice demonstrate fulminant 
apoptosis of the thymus and spleen and mice show nearly 
a complete loss of lymphocytes. Bcl-2 may have its most 
dramatic role in maintaining homeostasis n adult tissues. 
Of importance, Bcl-2 - / -  thymocytes require an apop- 
totic stimulus to manifest heir predisposition to massive 
cell death. This is reminiscent of studies of overexpressed 
Bax. In many respects Bcl-2 deficient cells represent a
rheostat reset o excess Bax/Bax (Fig. 4). The capacity of 
most organs to successfully complete development in Bcl-2 
deficient mice is remarkable. This may reflect an expand- 
ing family of Bcl-2 related molecules, Bcl-x [30], Mcl-1 
[31], AI [32] (Fig. 3) that may provide redundancy in 
death repressor activity during development. Consequently 
strategies which alter ratios of Bcl-2 to Bax or disrupt 
Bcl-2/Bax heterodimers might be tolerated in many cell 
types yet prove an effective means to promote cell death in 
others. 
7. Loss of function: bcl-2 deficient mice display fulmi- 
nant lymphoid apoptosis 
Within the embryo, Bcl-2 is expressed much more 
widely than in adult tissues. This raised questions as to 
whether this central repressor of cell death would be 
required for the successful development of multiple lin- 
eages. Bcl-2 deficient mice were created by gene targeting 
in embryonic stem (ES) cells [28]. Bcl-2 - / -  mice 
complete mbryonic development and appear normal for 
the first week. The spectrum of hematopoiesis including B 
and T cell differentiation is initially normal. Thus, Bcl-2 is 
not absolutely required for the development of those lin- 
eages. 
The development of most organs were histologically 
normal in Bcl-2 - / -  mice. However, after 1 week they 
display growth retardation, small external ears, immature 
facial features and early mortality. Bcl-2 - / -  mice 
display markedly hypoplastic renal development and 
progress to severe polycystic kidney disease (PKD). In 
particular Bcl-2 / mice demonstrate fulminant 
metanephric apoptosis at embryonic day 12. This is espe- 
cially prominent within the mesenchyme at the time of its 
induction by ureteric bud [29]. 
Hair growth in the mouse is cyclical. Bcl-2 - / - mice 
have initially normal hair pigmentation. However, with the 
second hair follicle cycle Bcl-2 - / -  mice turn gray. A 
key intermediate in melanin synthesis, DOPA-quinone, is 
an extremely reactive compound that undergoes cycliza- 
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